PPP2R5D NEURODEVELOPMENTAL DISORDER

Clinical trials for PPP2R5D NEURODEVELOPMENTAL DISORDER explained in plain language.

Never miss a new study

Get alerted when new PPP2R5D NEURODEVELOPMENTAL DISORDER trials appear

Sign up with your email to follow new studies for PPP2R5D NEURODEVELOPMENTAL DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug tested for rare genetic brain disorder

Disease control Ongoing

This study is testing whether an investigational drug called zatolmilast is safe and tolerable for people with Jordan's Syndrome, a rare genetic disorder that affects brain development. It involves about 30 participants aged 9 to 45 who have a confirmed diagnosis. The main goal i…

Matched conditions: PPP2R5D NEURODEVELOPMENTAL DISORDER

Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

PPP2R5D NEURODEVELOPMENTAL DISORDER

Get alerted when new PPP2R5D NEURODEVELOPMENTAL DISORDER trials appear

New drug tested for rare genetic brain disorder